OncoTherapy Science, Inc. To Start Clinical Trials Of OTS102 Angiogenesis Inhibitor 
10/19/2005 5:13:15 PM

Tokyo (JCNN) - OncoTherapy Science announced on April 4 that the company has decided to start clinical trials of OTS102, an angeiogensis inhibitor for cancer treatment. The company plans to begin a Phase I clinical trial within fiscal 2005.